1
2
Dec. 8, 2021 —Sonodynamic therapy uses ultrasound in combination with drugs to release harmful reactive oxygen species (ROS) at the site of a tumor. However, the treatment isn't very effective because cancer ...
June 24, 2021 —Drugs targeting the gene MAGEA3 may help block the growth of hepatocellular carcinoma (HCC), the most common type of primary liver cancer and one of the leading causes of cancer deaths in the ...
May 26, 2022 —The characterization a new molecular type of high-risk pediatric liver cancer showed that these tumors had better outcomes when patients were treated by transplantation, rather than by chemotherapy ...
Aug. 15, 2022 —A hormone secreted by fat cells can restrain the growth of liver tumors in mice, according to a new ...
Nov. 3, 2022 —Researchers have published new study findings that establish rationale for the use of a class of drugs known as MDA-9 inhibitors as a potential treatment option for aggressive liver ...
Aug. 2, 2022 —Liver cancer's rapid growth leads to a vulnerability in its energy-production and cell-building processes that may be potently exploited with a new combination-treatment strategy, according to a ...
June 22, 2022 —An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an excess of fat in liver cells that can cause chronic inflammation and liver damage, increasing the risk ...
July 30, 2021 —Researchers have shown that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer, according to a ...
Aug. 26, 2020 —Researchers have taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver ...
Nov. 30, 2020 —A combination cancer therapy that is effective against treatment-resistant hepatocellular carcinoma (HCC) by inhibiting tumor growth and increasing survival has been identified. The dual therapy -- ...